Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.

To obtain more information of the functional domains of the NPC1 protein, the mutational spectrum and the level of immunoreactive protein were investigated in skin fibroblasts from 30 unrelated patients with Niemann-Pick C1 disease. Nine of them were characterized by mild alterations of cellular cholesterol transport (the "variant" biochemical phenotype). The mutations showed a wide distribution to nearly all NPC1 domains, with a cluster (11/32) in a conserved NPC1 cysteine-rich luminal loop. Homozygous mutations in 14 patients and a phenotypically defined allele, combined with a new mutation, in a further 10 patients allowed genotype/phenotype correlations. Premature-termination-codon mutations, the three missense mutations in the sterol-sensing domain (SSD), and A1054T in the cysteine-rich luminal loop all occurred in patients with infantile neurological onset and "classic" (severe) cholesterol-trafficking alterations. By western blot, NPC1 protein was undetectable in the SSD missense mutations studied (L724P and Q775P) and essentially was absent in the A1054T missense allele. Our results thus enhance the functional significance of the SSD and demonstrate a correlation between the absence of NPC1 protein and the most severe neurological form. In the remaining missense mutations studied, corresponding to other disease presentations (including two adults with nonneurological disease), NPC1 protein was present in significant amounts of normal size, without clear-cut correlation with either the clinical phenotype or the "classic"/"variant" biochemical phenotype. Missense mutations in the cysteine-rich luminal loop resulted in a wide array of clinical and biochemical phenotypes. Remarkably, all five mutant alleles (I943M, V950M, G986S, G992R, and the recurrent P1007A) definitively correlated with the "variant" phenotype clustered within this loop, providing new insight on the functional complexity of the latter domain.

[1]  U. Rühl,et al.  [Ultrasound echogenic splenic tumors: nodular manifestation of type C Niemann-Pick disease]. , 2008, Ultraschall in der Medizin.

[2]  G. Millat,et al.  Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations , 2001, Human Genetics.

[3]  H. Watari,et al.  Sterol-modulated Glycolipid Sorting Occurs in Niemann-Pick C1 Late Endosomes* , 2001, The Journal of Biological Chemistry.

[4]  Ta-Yuan Chang,et al.  Fate of Endogenously Synthesized Cholesterol in Niemann-Pick Type C1 Cells* , 2000, The Journal of Biological Chemistry.

[5]  Y. Ioannou,et al.  Transmembrane molecular pump activity of Niemann-Pick C1 protein. , 2000, Science.

[6]  R. Wattiaux,et al.  Identification of HE1 as the second gene of Niemann-Pick C disease. , 2000, Science.

[7]  D. Ory Niemann-Pick type C: a disorder of cellular cholesterol trafficking. , 2000, Biochimica et biophysica acta.

[8]  K. Yamakawa,et al.  Genotype-phenotype relationship of Niemann-Pick disease type C: a possible correlation between clinical onset and levels of NPC1 protein in isolated skin fibroblasts , 2000, Journal of medical genetics.

[9]  C. Burd,et al.  Determinants of NPC1 expression and action: key promoter regions, posttranscriptional control, and the importance of a "cysteine-rich" loop. , 2000, Experimental cell research.

[10]  Yiannis A. Ioannou,et al.  Topological Analysis of Niemann-Pick C1 Protein Reveals That the Membrane Orientation of the Putative Sterol-sensing Domain Is Identical to Those of 3-Hydroxy-3-methylglutaryl-CoA Reductase and Sterol Regulatory Element Binding Protein Cleavage-activating Protein* , 2000, The Journal of Biological Chemistry.

[11]  W. Kleijer,et al.  Deficient ferritin immunoreactivity in tissues from niemann-pick type C patients: extension of findings to fetal tissues, H and L ferritin isoforms, but also one case of the rare Niemann-Pick C2 complementation group. , 2000, Molecular genetics and metabolism.

[12]  E. J. Blanchette-Mackie,et al.  Intracellular cholesterol trafficking: role of the NPC1 protein. , 2000, Biochimica et biophysica acta.

[13]  G. Millat,et al.  Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. , 1999, American journal of human genetics.

[14]  M. Dobson,et al.  Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain. , 1999, American journal of human genetics.

[15]  C. Tomasetto,et al.  Niemann-Pick C disease : insight from studies on mutated NPC1 gene and protein , 1999 .

[16]  Y. Ioannou,et al.  Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. , 1999, Molecular genetics and metabolism.

[17]  K. G. Coleman,et al.  The genomic organization and polymorphism analysis of the human Niemann-Pick C1 gene. , 1999, Biochemical and biophysical research communications.

[18]  H. Watari,et al.  Mutations in the Leucine Zipper Motif and Sterol-sensing Domain Inactivate the Niemann-Pick C1 Glycoprotein* , 1999, The Journal of Biological Chemistry.

[19]  K. Higaki,et al.  NPC1 gene mutations in Japanese patients with Niemann-Pick disease type C , 1999, Human Genetics.

[20]  M. Patterson,et al.  The Niemann-Pick C1 Protein Resides in a Vesicular Compartment Linked to Retrograde Transport of Multiple Lysosomal Cargo* , 1999, The Journal of Biological Chemistry.

[21]  M. Dobson,et al.  The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097-->T transversion in NPC1. , 1998, American journal of human genetics.

[22]  Kinuko Suzuki,et al.  Recent Advances in Elucidating Niemann‐Pick C Disease , 1998, Brain pathology.

[23]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[24]  S. Steinberg,et al.  Complementation studies in Niemann-Pick disease type C indicate the existence of a second group. , 1994, Journal of medical genetics.

[25]  R. Rousson,et al.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. , 1991, Biochimica et biophysica acta.

[26]  E. Fröhlich1,et al.  Sonographisch echodichte Milztumoren: Knotige Manifestation eines Morbus Niemann-Pick Typ C , 1990 .

[27]  F. Palmer,et al.  Defective activity of acyl-CoA:cholesterol O-acyltransferase in Niemann-Pick type C and type D fibroblasts. , 1989, The Biochemical journal.

[28]  M. B. Ben Dridi,et al.  [Early infantile form of Niemann-Pick disease type C. Apropos of 2 siblings]. , 1989, Annales de pediatrie.

[29]  R. Brady,et al.  Niemann‐Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification: A collaborative study on 70 patients , 1988, Clinical genetics.

[30]  M. Jeanpierre A rapid method for the purification of DNA from blood. , 1987, Nucleic acids research.

[31]  J. Martín,et al.  Juvenile dystonic lipidosis (variant of Niemann-Pick disease type C) , 1984, Journal of the Neurological Sciences.

[32]  D. Wenger,et al.  Lactosyl ceramidosis: normal activity for two lactosyl ceramide beta-galactosidases. , 1975, Science.

[33]  G. Dawson Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosyl hydrolase deficiency: lactosylceramidosis. , 1972, Journal of lipid research.

[34]  R. Matalon,et al.  Lactosylceramidosis: lactosylceramide galactosyl hydrolase deficiency and accumulation of lactosylceramide in cultured skin fibroblasts. , 1971, The Journal of pediatrics.

[35]  C. Beesley,et al.  Genotype-phenotype relationship of Niemann-Pick disease type C : a possible correlation between clinical onset and levels of NPC 1 protein in isolated skin fibroblasts , 2000 .

[36]  E. Carstea,et al.  Genetic heterogeneity in Niemann-Pick C disease: a study using somatic cell hybridization and linkage analysis. , 1996, American journal of human genetics.

[37]  H. Sakuraba,et al.  Accumulation of GM2 Ganglioside in Niemann-Pick Disease Type C Fibroblasts , 1996 .

[38]  E. Eggermont,et al.  Niemann-Pick type C disease and early cholestasis in three brothers. , 1980, Acta paediatrica Belgica.